Chemoinformaics analysis of BORNYL-6-O-BETA-D-XYLOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE
| Molecular Weight | 448.509 | nRot | 5 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 20 |
| Exact Molecular Weight | 448.231 | nRing | 4 |
| Solubility: LogS | -1.617 | nHRing | 2 |
| Solubility: LogP | -0.594 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 67.0946 |
| nHD | 6 | BPOL | 43.0595 |
| QED | 0.292 |
| Synth | 5.456 |
| Natural Product Likeliness | 2.279 |
| NR-PPAR-gamma | 0.143 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.141 |
| HIA | 0.953 |
| CACO-2 | -5.361 |
| MDCK | 0.000122037 |
| BBB | 0.274 |
| PPB | 0.373701 |
| VDSS | 0.432 |
| FU | 0.515068 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.062 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.271 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.151 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.172 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.017 |
| CL | 1.145 |
| T12 | 0.185 |
| hERG | 0.025 |
| Ames | 0.263 |
| ROA | 0.232 |
| SkinSen | 0.031 |
| Carcinogencity | 0.048 |
| EI | 0.01 |
| Respiratory | 0.084 |
| NR-Aromatase | 0.343 |
| Antiviral | Yes |
| Prediction | 0.826809 |